- Home
- OPTX vs VTVT Comparison
OPTX vs VTVT Comparison
Compare OPTX & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPTX
- VTVT
- Stock Information
- Founded
- OPTX 1981
- VTVT 2015
- Country
- OPTX United States
- VTVT United States
- Employees
- OPTX N/A
- VTVT N/A
- Industry
- OPTX Blank Checks
- VTVT Biotechnology: Pharmaceutical Preparations
- Sector
- OPTX Finance
- VTVT Health Care
- Exchange
- OPTX Nasdaq
- VTVT Nasdaq
- Market Cap
- OPTX 51.9M
- VTVT 56.7M
- IPO Year
- OPTX N/A
- VTVT 2015
- Fundamental
- Price
- OPTX $1.66
- VTVT $15.89
- Analyst Decision
- OPTX
- VTVT Strong Buy
- Analyst Count
- OPTX 0
- VTVT 2
- Target Price
- OPTX N/A
- VTVT $35.50
- AVG Volume (30 Days)
- OPTX 56.1K
- VTVT 5.8K
- Earning Date
- OPTX 06-13-2025
- VTVT 05-15-2025
- Dividend Yield
- OPTX N/A
- VTVT N/A
- EPS Growth
- OPTX N/A
- VTVT N/A
- EPS
- OPTX 0.00
- VTVT N/A
- Revenue
- OPTX $29,392,186.00
- VTVT $17,000.00
- Revenue This Year
- OPTX N/A
- VTVT N/A
- Revenue Next Year
- OPTX N/A
- VTVT N/A
- P/E Ratio
- OPTX $997.14
- VTVT N/A
- Revenue Growth
- OPTX 4.36
- VTVT N/A
- 52 Week Low
- OPTX $0.85
- VTVT $12.12
- 52 Week High
- OPTX $8.39
- VTVT $26.99
- Technical
- Relative Strength Index (RSI)
- OPTX 56.12
- VTVT 34.47
- Support Level
- OPTX $1.33
- VTVT $15.91
- Resistance Level
- OPTX $1.85
- VTVT $18.09
- Average True Range (ATR)
- OPTX 0.16
- VTVT 1.09
- MACD
- OPTX 0.02
- VTVT -0.68
- Stochastic Oscillator
- OPTX 56.90
- VTVT 5.09
About OPTX Syntec Optics Holdings Inc.
Syntec Optics Holdings Inc is vertically integrated from design and component manufacturing for lens system assembly to imaging module integration for system solutions. Making its tools, molding, and nano machining allows close interaction and recut ability, enabling special techniques to hold tolerances to sub-micron levels. It has steadily developed a variety of other complementary manufacturing techniques to provide a wide suite of horizontal capabilities including thin film deposition coatings, glass molding, polymer molding, tool-making, mechanical manufacturing, and nano machining.
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its product pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.